SCHEMBL30962908

SCHEMBL30962908

COc1nc(Nc2ccc(C3CCN(C)CC3)c(C)c2)ncc1C(=O)Nc1c(Cl)ccc(O[Si](C)(C)C(C)(C)C)c1C

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ WEE1 P30291 1/20 0.43
▸ LCK P06239 3/20 0.41
▸ JAK3 P52333 2/20 0.41
▸ KDR P35968 1/20 0.41
▸ TEK Q02763 1/20 0.41
▸ MAPK14 Q16539 1/20 0.41
▸ SRC P12931 6/20 0.40
▸ SIK1 P57059 2/20 0.40
▸ SIK2 Q9H0K1 2/20 0.40
▸ SIK3 Q9Y2K2 2/20 0.40
▸ TNK2 Q07912 1/20 0.39
▸ BRD4 O60885 6/20 0.39
▸ JAK2 O60674 1/20 0.38
▸ JAK1 P23458 1/20 0.38
▸ BRDT Q58F21 1/20 0.38
▸ AXL P30530 1/20 0.38
▸ TYRO3 Q06418 1/20 0.38
▸ MERTK Q12866 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962922 0.95 WEE1 (0.44) WEE1LCKJAK3KDRTEK
SCHEMBL30962817 0.94 LCK (0.43) WEE1LCKJAK3KDRTEK
SCHEMBL30962719 0.92 PTK2 (0.40) WEE1LCKJAK3KDRTEK
SCHEMBL30962750 0.91 TTK (0.40) LCKJAK3KDRTEKMAPK14
SCHEMBL30962685 0.89 SRC (0.38) LCKJAK3KDRTEKMAPK14
SCHEMBL30962812 0.88 WEE1 (0.47) WEE1LCKJAK3KDRTEK
SCHEMBL30962941 0.87 LCK (0.44) WEE1LCKJAK3KDRTEK
SCHEMBL27313416 0.86 WEE1 (0.54) WEE1LCKJAK3KDRTEK
SCHEMBL30962868 0.85 WEE1 (0.51) WEE1LCKJAK3KDRTEK
SCHEMBL30962699 0.85 SRC (0.53) WEE1LCKJAK3KDRTEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback